Skip to content
Search

Latest Stories

Community Mental Health survey reveals only 39% felt supported by NHS mental health services

Community Mental Health survey reveals only 39% felt supported by NHS mental health services
According to the community mental health survey, 42 per cent felt unsupported during critical waiting periods

The NHS Long Term Plan and NHS Mental Health implementation plan requires the National Health Services to treat mental health with the same urgency as physical health.

However, the recently published Community Mental Health Survey 2023 by the Care Quality Commission (CQC) has shed light on the substandard quality of care experienced by individuals in the community across different aspects of care provision.


With feedback from 14,770 respondents including responses from 16- and 17-year-olds, who received treatment for mental health conditions between April 1 and May 31, 2023, the survey outcomes highlight deficiencies in quality of care, crisis intervention, support during waiting periods, care planning, and involvement in decision-making processes.

While some positive findings emerged, such as high levels of satisfaction with medication reviews and privacy during therapy sessions, significant shortcomings remain apparent.

Alarmingly, less than half of respondents (39 per cent) felt they received the necessary assistance during their last interaction with mental health services, and only 50 per cent believed they were allocated sufficient time to discuss their needs and treatment.

Of particular concern were experiences during waiting periods, with nearly 44 per cent reporting deteriorating mental health while awaiting treatment.

Furthermore, 42 per cent of respondents felt unsupported between assessment and initial treatment appointments, with 40 per cent expressing dissatisfaction with waiting times.

For the first time, the survey highlighted respondents using Child and Adolescent Mental Health Services (CAMHS), revealing subpar experiences across several domains.

Moreover, discussions on medication side effects and discontinuation were less frequent.

The survey also identified critical areas for improvement, particularly in crisis care and support during waiting periods.

Sir Julian Hartley, chief executive of NHS Providers, expressed deep concern over the regulator's findings, emphasising the pressing need to address the challenges faced by these vital services amidst soaring demand.

"NHS trusts will be very concerned by the regulator's findings and are determined to do everything they can to give people the care they need in the face of record demand," he said.

"It's clear that under-pressure services have more to do to ensure that people get timely, high-quality care and support but to aid trusts' efforts we need broader, cross-government action to address the gap between demand for mental health care and trusts' ability to provide it." he added further.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less